MedTrace Logo

Effects of ElevATP on Body Composition and Athletic Performance

NCT02819219 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2016-06-30

No results posted yet for this study

Summary

This study will examine the effects of supplemental ElevATP with or without a blend of extended-release caffeine and B vitamins for changes in body composition, athletic performance, and hematology over a 12 week intervention period.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Supplemental

participants were provided with either placebo, placebo + ElevATP, or placebo + ElevATP + Caffeine + Vitamins.

OTHER

Exercise Intervention

Concurrent with the supplemental intervention, all subjects participated in a resistance exercise intervention.

Sponsors & Collaborators

  • VDF FutureCeuticals Inc.

    collaborator INDUSTRY

  • MusclePharm Sports Science Institute

    lead INDUSTRY

Principal Investigators

  • jordan m joy, ms · MusclePharm Sports Science Institute

Study Design

Allocation
RANDOMIZED
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2014-12-31
Completion
2014-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02819219 on ClinicalTrials.gov